Literature DB >> 8230455

Identification of the activation domain of equine infectious anemia virus rev.

R A Fridell1, K M Partin, S Carpenter, B R Cullen.   

Abstract

Several members of the lentivirus family of complex retroviruses have been shown to encode proteins that are functionally equivalent to the Rev posttranscriptional regulatory protein of human immunodeficiency virus type 1 (HIV-1). Furthermore, the domain organization of HIV-1 Rev, featuring a highly basic N-terminal RNA binding domain and a leucin-rich C-terminal effector domain, has also been shown to be highly conserved among Rev proteins derived from not only the primate but also the ovine and caprine lentiviruses. Although it has therefore appeared highly probable that the lentivirus equine infectious anemia virus (EIAV) also encodes a Rev, the predicted amino acid sequence of this putative EIAV regulatory protein does not display any evident homology to the basic and leucine-rich motifs characteristic of other known Rev proteins. By fusion of different segments of the proposed EIAV Rev protein to the well-defined RNA binding domain of either HIV-1 or visna virus Rev, we have identified a segment of this EIAV protein that can efficiently substitute in cis for the otherwise essential activation motif. Interestingly, the minimal EIAV Rev activation motif identified in this study comprises approximately 18 amino acids located toward the protein N terminus that lack any evident similarity to the leucine-rich activation domains found in these other lentivirus Rev proteins. It therefore appears that the Rev protein of EIAV, while analogous in function to Rev proteins defined in lentiviruses of primate, ovine, and caprine origin, is nevertheless distinguished by an entirely novel domain organization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230455      PMCID: PMC238195     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

2.  Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.

Authors:  K Rushlow; K Olsen; G Stiegler; S L Payne; R C Montelaro; C J Issel
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

3.  Characterization of a cDNA clone encoding the visna virus transactivating protein.

Authors:  J L Davis; J E Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein.

Authors:  S Kubota; H Siomi; T Satoh; S Endo; M Maki; M Hatanaka
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

5.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

7.  Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

Authors:  M H Malim; S Böhnlein; J Hauber; B R Cullen
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

8.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

9.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

10.  Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.

Authors:  M H Malim; S Böhnlein; R Fenrick; S Y Le; J V Maizel; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more
  34 in total

1.  An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.

Authors:  J Yang; H P Bogerd; S Peng; H Wiegand; R Truant; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Identification of novel Saccharomyces cerevisiae proteins with nuclear export activity: cell cycle-regulated transcription factor ace2p shows cell cycle-independent nucleocytoplasmic shuttling.

Authors:  T H Jensen; M Neville; J C Rain; T McCarthy; P Legrain; M Rosbash
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs.

Authors:  J Bear; W Tan; A S Zolotukhin; C Tabernero; E A Hudson; B K Felber
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals.

Authors:  B E Meyer; J L Meinkoth; M H Malim
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.

Authors:  M E Harris; R R Gontarek; D Derse; T J Hope
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay.

Authors:  H P Bogerd; R A Fridell; R E Benson; J Hua; B R Cullen
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.

Authors:  Y Luo; H Yu; B M Peterlin
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

9.  Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.

Authors:  K Engel; A Kotlyarov; M Gaestel
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.

Authors:  Wendy O Sparks; Karin S Dorman; Sijun Liu; Susan Carpenter
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.